Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usman Baber

Showing results (11-20 of 391) with videos related to

Pageof 40
Sort By:
JACC. Cardiovascular Interventions|January 4, 2023
Switching Between Intravenous and Oral P2Y<sub>12</sub> Inhibition: Easier Said Than DoneUsman Baber
Journal of the American College of Cardiology|July 10, 2024
Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?Usman Baber
Journal of the American College of Cardiology|July 23, 2021
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a ReappraisalUsman Baber
JACC. Cardiovascular Interventions|January 23, 2025
Bleeding Risk After PCI: Do We Need Another Score?Usman Baber
JACC. Cardiovascular Interventions|February 14, 2024
Inflammatory Potential and Risk Prediction After PCI in High Bleeding Risk PatientsUsman Baber
Nature Reviews. Cardiology|September 28, 2011
Acute coronary syndromes: Antithrombotics in ACS--moving beyond unfractionated heparinUsman Baber, Roxana Mehran
Nature Reviews. Nephrology|March 14, 2012
Prevention of contrast-induced AKI--the ongoing sagaUsman Baber, Roxana Mehran
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 23, 2020
Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines?Usman Baber, Roxana Mehran
Current Opinion in Cardiology|May 3, 2017
Antiplatelet treatments: recent evidence from randomized controlled trialsBirgit Vogel, Usman Baber
JAMA Cardiology|August 23, 2016
Predicting Risk of Ischemic or Bleeding Events After Percutaneous Coronary InterventionRoxana Mehran, Usman Baber
Pageof 40

Showing results (11-20 of 391) with videos related to

Sort By:
Pageof 40
JACC. Cardiovascular Interventions|January 4, 2023
Switching Between Intravenous and Oral P2Y<sub>12</sub> Inhibition: Easier Said Than DoneUsman Baber
Journal of the American College of Cardiology|July 10, 2024
Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?Usman Baber
Journal of the American College of Cardiology|July 23, 2021
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a ReappraisalUsman Baber
JACC. Cardiovascular Interventions|January 23, 2025
Bleeding Risk After PCI: Do We Need Another Score?Usman Baber
JACC. Cardiovascular Interventions|February 14, 2024
Inflammatory Potential and Risk Prediction After PCI in High Bleeding Risk PatientsUsman Baber
Nature Reviews. Cardiology|September 28, 2011
Acute coronary syndromes: Antithrombotics in ACS--moving beyond unfractionated heparinUsman Baber, Roxana Mehran
Nature Reviews. Nephrology|March 14, 2012
Prevention of contrast-induced AKI--the ongoing sagaUsman Baber, Roxana Mehran
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 23, 2020
Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines?Usman Baber, Roxana Mehran
Current Opinion in Cardiology|May 3, 2017
Antiplatelet treatments: recent evidence from randomized controlled trialsBirgit Vogel, Usman Baber
JAMA Cardiology|August 23, 2016
Predicting Risk of Ischemic or Bleeding Events After Percutaneous Coronary InterventionRoxana Mehran, Usman Baber
Pageof 40